GOLDMAN SACHS GROUP INC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 107 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,797,788
+29.1%
600,474
+40.6%
0.00%0.0%
Q2 2023$3,715,344
+79.9%
427,051
-39.2%
0.00%
Q1 2023$2,065,591
-22.6%
702,582
-7.9%
0.00%
-100.0%
Q4 2022$2,669,762
-60.4%
762,789
-10.5%
0.00%
-50.0%
Q3 2022$6,745,000
-3.4%
852,705
-3.9%
0.00%0.0%
Q2 2022$6,985,000
-34.0%
887,632
+1.9%
0.00%0.0%
Q1 2022$10,584,000
+39.0%
871,101
+40.0%
0.00%0.0%
Q4 2021$7,614,000
+1770.8%
622,018
+1491.1%
0.00%
Q3 2021$407,000
-81.4%
39,093
-83.9%
0.00%
Q2 2021$2,186,000
+56.1%
243,138
+76.4%
0.00%
Q1 2021$1,400,000137,8370.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
WOODSTOCK CORP 22,253$514,2670.06%
MASSMUTUAL TRUST CO FSB/ADV 108$2,4960.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders